Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
68 studies found for:    Open Studies | digestive disease | NIDDK
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of People With Gastrointestinal Disease
Condition: Gastrointestinal Diseases
Intervention:
2 Recruiting A New Method for Determining Gastric Acid Output Using a Wireless Capsule
Condition: Gastrointestinal Diseases
Intervention:
3 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
Intervention:
4 Recruiting SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis (EoE)
Interventions: Other: elimination diet therapy;   Drug: Flovent
5 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
Intervention:
6 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
Intervention:
7 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
Intervention:
8 Recruiting Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
Condition: Fatty Liver
Intervention:
9 Recruiting Longitudinal Study of Mitochondrial Hepatopathies
Conditions: Acute Liver Failure,;   Mitochondrial Diseases;   End Stage Liver Disease,;   Respiratory Chain Deficiencies, Mitochondrial;   Disorder of Fatty Acid Oxidation
Intervention:
10 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;   Drug: Vitamin E 400 IU/d;   Drug: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
11 Recruiting Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
Conditions: Healthy;   NAFLD (Non-Alcoholic Fatty Liver Disease);   NASH (Non-Alcoholic Steatohepatitis)
Interventions: Other: NAFLD/NASH - Placebo;   Dietary Supplement: NAFLD/NASH - Vitamin E
12 Recruiting DILIN's Prospective Study
Condition: Liver Diseases
Intervention:
13 Recruiting Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Condition: Cirrhosis
Intervention:
14 Recruiting Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
Condition: Post-ERCP Pancreatitis
Interventions: Other: Indomethacin 100 mg rectally immediately after ERCP, NO prophylactic pancreatic stent placement;   Other: Indomethacin 100 mg rectally immediately after ERCP AND prophylactic pancreatic stent placement
15 Recruiting Mesenchymal Stem Cell and Islet Co-transplantation
Conditions: Chronic Pancreatitis;   Diabetes
Intervention: Biological: autologous mesenchymal stromal cell
16 Recruiting Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Conditions: Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Gastroenteritis;   Eosinophilic Colitis
Intervention:
17 Recruiting A Multi-Center Trial to Study Acute Liver Failure in Adults
Conditions: Acute Liver Failure;   Fulminant Hepatic Failure;   Acute Liver Injury
Intervention:
18 Recruiting Gastroparesis Registry 2
Conditions: Gastroparesis;   Diabetic Gastroparesis;   Idiopathic Gastroparesis
Intervention:
19 Recruiting Biliary Atresia Research Consortium
Conditions: Biliary Atresia;   Cholestasis
Intervention:
20 Recruiting Biliary Atresia Study in Infants and Children
Condition: Biliary Atresia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.